Partial nephrogenic diabetes insipidus with a novel arginine vasopressin receptor 2 gene variant.

IF 1 Q4 ENDOCRINOLOGY & METABOLISM Clinical Pediatric Endocrinology Pub Date : 2022-01-01 Epub Date: 2021-11-01 DOI:10.1297/cpe.2021-0029
Atsushi Ishida, Haruo Mizuno, Kohei Aoyama, Shiori Sasaki, Yutaka Negishi, Takeshi Arakawa, Takayasu Mori
{"title":"Partial nephrogenic diabetes insipidus with a novel arginine vasopressin receptor 2 gene variant.","authors":"Atsushi Ishida,&nbsp;Haruo Mizuno,&nbsp;Kohei Aoyama,&nbsp;Shiori Sasaki,&nbsp;Yutaka Negishi,&nbsp;Takeshi Arakawa,&nbsp;Takayasu Mori","doi":"10.1297/cpe.2021-0029","DOIUrl":null,"url":null,"abstract":"<p><p>X-linked nephrogenic diabetes insipidus (NDI) is caused by variations in arginine vasopressin receptor 2 (<i>AVPR2</i>). Some patients show partial resistance to arginine vasopressin (AVP). A 19-month-old Japanese boy presented with polydipsia since infancy. His mother had a history of polydipsia during pregnancy, and his maternal granduncle also had polydipsia. Intermediate urine osmolality and markedly high plasma AVP levels were observed in the water deprivation test. Subsequent pitressin administration caused no further elevation in urine osmolality. We diagnosed the patient with partial NDI, initiated therapy with hydrochlorothiazide, and placed him on a low-sodium diet. Although his urine volume decreased by 20-30% after the initiation of therapy, progressive hydronephrosis and growth retardation developed 2 years later. We investigated his genetic background by multiplex targeted sequencing of genes associated with inherited renal diseases, including <i>AVPR2</i> and aquaporin-2 (<i>AQP2</i>). We identified a hemizygous missense variant in <i>AVPR2</i> NM_000054:c.371A>G,p.(Tyr124Cys) in the boy and a heterozygous variant in the mother at the same locus. Distinguishing partial NDI from primary polydipsia is difficult because of its mild symptoms. Markedly elevated plasma AVP levels with intermediate urine osmolality may suggest partial NDI, and genetic analysis can be useful for such patients.</p>","PeriodicalId":10678,"journal":{"name":"Clinical Pediatric Endocrinology","volume":null,"pages":null},"PeriodicalIF":1.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/19/88/cpe-31-044.PMC8713061.pdf","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Pediatric Endocrinology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1297/cpe.2021-0029","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/11/1 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 1

Abstract

X-linked nephrogenic diabetes insipidus (NDI) is caused by variations in arginine vasopressin receptor 2 (AVPR2). Some patients show partial resistance to arginine vasopressin (AVP). A 19-month-old Japanese boy presented with polydipsia since infancy. His mother had a history of polydipsia during pregnancy, and his maternal granduncle also had polydipsia. Intermediate urine osmolality and markedly high plasma AVP levels were observed in the water deprivation test. Subsequent pitressin administration caused no further elevation in urine osmolality. We diagnosed the patient with partial NDI, initiated therapy with hydrochlorothiazide, and placed him on a low-sodium diet. Although his urine volume decreased by 20-30% after the initiation of therapy, progressive hydronephrosis and growth retardation developed 2 years later. We investigated his genetic background by multiplex targeted sequencing of genes associated with inherited renal diseases, including AVPR2 and aquaporin-2 (AQP2). We identified a hemizygous missense variant in AVPR2 NM_000054:c.371A>G,p.(Tyr124Cys) in the boy and a heterozygous variant in the mother at the same locus. Distinguishing partial NDI from primary polydipsia is difficult because of its mild symptoms. Markedly elevated plasma AVP levels with intermediate urine osmolality may suggest partial NDI, and genetic analysis can be useful for such patients.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
部分肾源性尿崩症伴精氨酸抗利尿素受体2基因变异。
x连锁肾源性尿崩症(NDI)是由精氨酸抗利尿素受体2 (AVPR2)变异引起的。部分患者对精氨酸抗利尿激素(AVP)表现出部分耐药。一个19个月大的日本男孩从婴儿期开始就表现为渴渴。他的母亲在怀孕期间有渴饮史,他的外祖父也有渴饮史。在缺水试验中观察到中度尿渗透压和明显高的血浆AVP水平。随后给药吡脲素未引起尿渗透压进一步升高。我们诊断患者为部分NDI,开始使用氢氯噻嗪治疗,并给予他低钠饮食。虽然他的尿量在治疗开始后减少了20-30%,但2年后出现了进行性肾积水和生长迟缓。我们通过对遗传肾病相关基因AVPR2和水通道蛋白-2 (AQP2)的多重靶向测序来研究他的遗传背景。我们在男孩的AVPR2 NM_000054:c.371A>G,p.(Tyr124Cys)中发现了一个半合子错义变体,在母亲的同一位点发现了一个杂合变体。由于其症状轻微,区分部分NDI与原发性多饮困难。血浆AVP水平明显升高且尿渗透压中等可能提示部分NDI,基因分析对此类患者有用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Clinical Pediatric Endocrinology
Clinical Pediatric Endocrinology ENDOCRINOLOGY & METABOLISM-
CiteScore
2.40
自引率
7.10%
发文量
34
期刊最新文献
A novel SOX2 frameshift pathogenic variant located in the transactivation domain in a male infant with hypogonadotropic hypogonadism. CHARGE syndrome in a child with a CHD7 variant and a novel pathogenic SOX2 variant: A case report. Familial and early recurrent pheochromocytoma in a child with a novel in-frame duplication variant of VHL. Hearing loss with two pathogenic SLC26A4 variants and positive thyroid autoantibody: A case report. Initial clinical manifestations in a young male with RFX6-variant-associated diabetes.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1